C12-NBD Ceramide
Manufacturer: Sigma Aldrich
CAS Number: 202850-01-9
Synonym(S): N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-erythro-sphingosine
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 MG | 810211C-1-MG | In Stock | ₹ 55,355.85 |
810211C - 1 MG
In Stock
Quantity
1
Base Price: ₹ 55,355.85
GST (18%): ₹ 9,964.053
Total Price: ₹ 65,319.903
Assay
>99% (TLC)
form
liquid
packaging
pkg of 1 × 1 mL (810211C-1mg)
manufacturer/tradename
Avanti Polar Lipids 810211C
concentration
1 mg/mL (810211C-1mg)
shipped in
dry ice
storage temp.
−20°C
InChI
1S/C36H61N5O6/c1-2-3-4-5-6-7-8-9-10-12-15-18-21-24-33(43)31(29-42)38-34(44)25-22-19-16-13-11-14-17-20-23-28-37-30-26-27-32(41(45)46)36-35(30)39-47-40-36/h21,24,26-27,31,33,37,42-43H,2-20,22-23,25,28-29H2,1H3,(H,38,44)/b24-21+/t31-,33+/m0/s1
InChI key
SNOJCYCOPNIGIK-ULETYAGTSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | C12-NBD Ceramide | Sigma Aldrich | ₹ 60,749.90 | |
 | 202850-01-9 | Dodecanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-12-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]- | A2B Chem | ₹ 13,860.72 - ₹ 1,10,286.84 |
Related Products
Description
- Application: C12-NBD ceramide is suitable for its use:as a substrate to measure the activity of acid, alkaline and neutral ceramidases[1]in in vitro ceramidase activity assay[2]in ceramide phosphoethanolamine (CPE) synthase assay to determine the Km and Vmax of sphingomyelin synthase (SMS1, SMS2, and SMSr)[3]
- Biochem/physiol Actions: Ceramide is one of the products of sphingolipid metabolism. The members of ceramide synthase family are responsible for its synthesis. Each ceramide synthesized differs in its acyl chain length. Ceramides possess a wide range of functions, associated with apoptosis, cancer inhibition and chemotherapy. Its action is also related to neurodegenerative diseases.[4]
- Packaging: 5 mL Amber Glass Screw Cap Vial (810211C-1mg)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
Target Organs
Central nervous system
WGK
WGK 3
Compare Similar Items
Show Difference
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810211C-1mg)
manufacturer/tradename: Avanti Polar Lipids 810211C
concentration: 1 mg/mL (810211C-1mg)
shipped in: dry ice
storage temp.: −20°C
InChI: 1S/C36H61N5O6/c1-2-3-4-5-6-7-8-9-10-12-15-18-21-24-33(43)31(29-42)38-34(44)25-22-19-16-13-11-14-17-20-23-28-37-30-26-27-32(41(45)46)36-35(30)39-47-40-36/h21,24,26-27,31,33,37,42-43H,2-20,22-23,25,28-29H2,1H3,(H,38,44)/b24-21+/t31-,33+/m0/s1
InChI key: SNOJCYCOPNIGIK-ULETYAGTSA-N
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (810211P-1mg)
manufacturer/tradename: Avanti Polar Lipids 810211P
concentration: __
shipped in: dry ice
storage temp.: −20°C
InChI: 1S/C36H61N5O6/c1-2-3-4-5-6-7-8-9-10-12-15-18-21-24-33(43)31(29-42)38-34(44)25-22-19-16-13-11-14-17-20-23-28-37-30-26-27-32(41(45)46)36-35(30)39-47-40-36/h21,24,26-27,31,33,37,42-43H,2-20,22-23,25,28-29H2,1H3,(H,38,44)/b24-21+/t31-,33+/m0/s1
InChI key: SNOJCYCOPNIGIK-ULETYAGTSA-N
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 50 μg (810215P-50ug)
manufacturer/tradename: Avanti Polar Lipids 810215P
concentration: __
shipped in: dry ice
storage temp.: −20°C
InChI: 1S/C18H39NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-17(21)18(22)16(19)15-20/h16-18,20-22H,2-15,19H2,1H3/t16-,17+,18-/m0/s1
InChI key: AERBNCYCJBRYDG-KSZLIROESA-N
